Doxorubicin hydrochloride
Doxorubicin hydrochloride (liposomal) is an antineoplastic prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain types of cancer, including ovarian cancer, multiple myeloma, and AIDS-related Kaposi sarcoma.
| Catalog Number | PIPE-0764 |
| Alternative Name(s) | Doxorubicin HCl Adriacin Rubex |
| Research Area | Natural Extract |
| Molecular Formula | C27H29NO11.ClH |
| CAS# | 25316-40-9 |
| Purity | 0.98% |
| SMILES | CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl |
| Size | inquiry |
| Supplier Page | https://www.protheragen-ing.com/doxorubicin-hydrochloride-item-9703.html |